This muscle loss is concerning because: It can impact metabolism and physical function It reduces your bodys ability to maintain blood sugar control It increases the risk of frailty as you age It creates a more challenging cycle once medications are discontinued 3
Periodic updates may be provided on companies, issuers or industries based on specific developments or announcements, market conditions or any other publicly available information
Approved by the FDA at the end of 2025 with a second product expected in April of this year, the oral GLP-1s are expected to open a new frontier for potential users including those hesitant to use injectable options
The packaging of some of these products carries the logos of state therapeutic products agencies, such as Swissmedic (Switzerland), the FDA (USA) or BfArM (Germany), as well as other imaginary certifications
Symptoms are usually moderate and disappear 8 days or less after their onset [18,46]